Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katja Steiger

Showing results (191-200 of 370) with videos related to

Pageof 37
Sort By:
Molecular Cancer Therapeutics|January 30, 2016
Modeling Therapy Response and Spatial Tissue Distribution of Erlotinib in Pancreatic CancerBarbara M Grüner, Isabel Winkelmann, Annette Feuchtinger, et al.
The American Journal of Pathology|September 18, 2016
Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse ModelAna Hidalgo-Sastre, Roxanne L Brodylo, Clara Lubeseder-Martellato, et al.
The Journal of Experimental Medicine|September 17, 2021
TIMP1 expression underlies sex disparity in liver metastasis and survival in pancreatic cancerChris D Hermann, Benjamin Schoeps, Celina Eckfeld, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 18, 2025
Detailed Characterization and Comparison of Mouse Models for CholangiocarcinomaMargaret Tulessin, Ludwig Beer, Stephanie Roessler, et al.
Pharmaceutics|January 28, 2026
Paving the Way for CCK2R-Targeted Peptide Receptor Radionuclide Therapy with [<sup>177</sup>Lu]Lu-DOTA-MGS5 in Patients with Small Cell Lung CancerTaraneh Sadat Zavvar, Giulia Santo, Leonhard Gruber, et al.
The American Journal of Surgical Pathology|May 16, 2017
A Novel Grading System Based on Tumor Budding and Cell Nest Size Is a Strong Predictor of Patient Outcome in Esophageal Squamous Cell CarcinomaMoritz Jesinghaus, Melanie Boxberg, Björn Konukiewitz, et al.
Frontiers in Oncology|April 16, 2021
PSMA Expression in Glioblastoma as a Basis for Theranostic Approaches: A Retrospective, Correlational Panel Study Including Immunohistochemistry, Clinical Parameters and PET ImagingAdrien Holzgreve, Annamaria Biczok, Viktoria C Ruf, et al.
Endocrine Pathology|November 6, 2025
Phenotypic Landscape of Pulmonary Neuroendocrine Tumors: Subtyped by OTP/ASCL1 Expression Correlated with Histology, Hormones and OutcomeAyako Ura, Katja Evert, Matthias Evert, et al.
Molecular Therapy Oncolytics|September 13, 2023
Interleukin-6-controlled, mesenchymal stem cell-based sodium/iodide symporter gene therapy improves survival of glioblastoma-bearing miceCarolin Kitzberger, Khuram Shehzad, Volker Morath, et al.
Journal of Fungi (Basel, Switzerland)|April 27, 2026
Correction: Maurer et al. Gut Microbial Disruption in Critically Ill Patients with COVID-19-Associated Pulmonary Aspergillosis. <i>J. Fungi</i> 2022, <i>8</i>, 1265H Carlo Maurer, David Schult, Plamena Koyumdzhieva, et al.
Pageof 37

Showing results (191-200 of 370) with videos related to

Sort By:
Pageof 37
Molecular Cancer Therapeutics|January 30, 2016
Modeling Therapy Response and Spatial Tissue Distribution of Erlotinib in Pancreatic CancerBarbara M Grüner, Isabel Winkelmann, Annette Feuchtinger, et al.
The American Journal of Pathology|September 18, 2016
Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse ModelAna Hidalgo-Sastre, Roxanne L Brodylo, Clara Lubeseder-Martellato, et al.
The Journal of Experimental Medicine|September 17, 2021
TIMP1 expression underlies sex disparity in liver metastasis and survival in pancreatic cancerChris D Hermann, Benjamin Schoeps, Celina Eckfeld, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 18, 2025
Detailed Characterization and Comparison of Mouse Models for CholangiocarcinomaMargaret Tulessin, Ludwig Beer, Stephanie Roessler, et al.
Pharmaceutics|January 28, 2026
Paving the Way for CCK2R-Targeted Peptide Receptor Radionuclide Therapy with [<sup>177</sup>Lu]Lu-DOTA-MGS5 in Patients with Small Cell Lung CancerTaraneh Sadat Zavvar, Giulia Santo, Leonhard Gruber, et al.
The American Journal of Surgical Pathology|May 16, 2017
A Novel Grading System Based on Tumor Budding and Cell Nest Size Is a Strong Predictor of Patient Outcome in Esophageal Squamous Cell CarcinomaMoritz Jesinghaus, Melanie Boxberg, Björn Konukiewitz, et al.
Frontiers in Oncology|April 16, 2021
PSMA Expression in Glioblastoma as a Basis for Theranostic Approaches: A Retrospective, Correlational Panel Study Including Immunohistochemistry, Clinical Parameters and PET ImagingAdrien Holzgreve, Annamaria Biczok, Viktoria C Ruf, et al.
Endocrine Pathology|November 6, 2025
Phenotypic Landscape of Pulmonary Neuroendocrine Tumors: Subtyped by OTP/ASCL1 Expression Correlated with Histology, Hormones and OutcomeAyako Ura, Katja Evert, Matthias Evert, et al.
Molecular Therapy Oncolytics|September 13, 2023
Interleukin-6-controlled, mesenchymal stem cell-based sodium/iodide symporter gene therapy improves survival of glioblastoma-bearing miceCarolin Kitzberger, Khuram Shehzad, Volker Morath, et al.
Journal of Fungi (Basel, Switzerland)|April 27, 2026
Correction: Maurer et al. Gut Microbial Disruption in Critically Ill Patients with COVID-19-Associated Pulmonary Aspergillosis. <i>J. Fungi</i> 2022, <i>8</i>, 1265H Carlo Maurer, David Schult, Plamena Koyumdzhieva, et al.
Pageof 37